These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2427245

  • 1. Glucagon: endocrine effects and calcium involvement in cardiovascular actions in dogs.
    Chernow B, Reed L, Geelhoed GW, Anderson M, Teich S, Meyerhoff J, Beardsley D, Lake CR, Holaday JW.
    Circ Shock; 1986; 19(4):393-407. PubMed ID: 2427245
    [Abstract] [Full Text] [Related]

  • 2. Glucagon's chronotropic action is calcium dependent.
    Chernow B, Zaloga GP, Malcolm D, Willey SC, Clapper M, Holaday JW.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):833-7. PubMed ID: 2885409
    [Abstract] [Full Text] [Related]

  • 3. Effects of beta-adrenergic blockade on plasma cyclic AMP and blood sugar responses to glucagon and isoproterenol in man.
    Messerli FH, Kuchel O, Tolis G, Hamet P, Fraysse J, Genest J.
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):189-94. PubMed ID: 187546
    [Abstract] [Full Text] [Related]

  • 4. Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion.
    Gustavson SM, Chu CA, Nishizawa M, Farmer B, Neal D, Yang Y, Vaughan S, Donahue EP, Flakoll P, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E534-44. PubMed ID: 12736160
    [Abstract] [Full Text] [Related]

  • 5. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O, Miles P, Wasserman D, Lickley L, Vranic M.
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [Abstract] [Full Text] [Related]

  • 6. Vascular and metabolic effects of circulating epinephrine and norepinephrine. Concentration-effect study in dogs.
    Hjemdahl P, Belfrage E, Daleskog M.
    J Clin Invest; 1979 Nov; 64(5):1221-8. PubMed ID: 227927
    [Abstract] [Full Text] [Related]

  • 7. The effect of beta-adrenergic blockade on the cardiovascular response to diltiazem or verapamil in dogs.
    Sullivan KB, Kapur PA.
    Anesth Analg; 1986 Nov; 65(11):1099-106. PubMed ID: 3021022
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism.
    Yalcin M, Aydin C.
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular excitatory effect on rats of a fraction isolated from the eyestalk of shrimp: Peneaus vanameii.
    Rosa F, Cedeño J, León L, Estrada O, Romero-Vecchione E, Vásquez J, Antequera R.
    Invest Clin; 2006 Jun; 47(2):133-41. PubMed ID: 16886775
    [Abstract] [Full Text] [Related]

  • 10. Glucagon and the circulation.
    Farah AE.
    Pharmacol Rev; 1983 Sep; 35(3):181-217. PubMed ID: 6318231
    [Abstract] [Full Text] [Related]

  • 11. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A, Hermes U, Schäfers RF, Wenzel R, von Birgelen C, Brodde OE.
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [Abstract] [Full Text] [Related]

  • 12. Receptors, adenylate cyclase, depression, and lithium.
    Belmaker RH.
    Biol Psychiatry; 1981 Apr; 16(4):333-50. PubMed ID: 6261845
    [Abstract] [Full Text] [Related]

  • 13. Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade.
    Hood SG, Watson AM, May CN.
    Peptides; 2005 Jul; 26(7):1248-56. PubMed ID: 15949643
    [Abstract] [Full Text] [Related]

  • 14. Effects of mu-opioid receptor stimulation in the hypothalamic paraventricular nucleus on basal and stress-induced catecholamine secretion and cardiovascular responses.
    Kiritsy-Roy JA, Appel NM, Bobbitt FG, Van Loon GR.
    J Pharmacol Exp Ther; 1986 Dec; 239(3):814-22. PubMed ID: 3025420
    [Abstract] [Full Text] [Related]

  • 15. A review of potential cardiovascular uses of intravenous glucagon administration.
    White CM.
    J Clin Pharmacol; 1999 May; 39(5):442-7. PubMed ID: 10234590
    [Abstract] [Full Text] [Related]

  • 16. Comparison of calcium channel inhibitors on vagal heart rate responses elicited by arterial baroreceptor reflexes in anesthetized dogs.
    Taylor DG, Kowalski TE.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):491-9. PubMed ID: 6694122
    [Abstract] [Full Text] [Related]

  • 17. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA, Cryer PE, Haymond MW, Gerich JE.
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [Abstract] [Full Text] [Related]

  • 18. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man.
    Ball JH, Kaminsky NI, Hardman JG, Broadus AE, Sutherland EW, Liddle GW.
    J Clin Invest; 1972 Aug; 51(8):2124-9. PubMed ID: 4403383
    [Abstract] [Full Text] [Related]

  • 19. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV.
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [Abstract] [Full Text] [Related]

  • 20. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine.
    Kline JA, Tomaszewski CA, Schroeder JD, Raymond RM.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):744-50. PubMed ID: 8246150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.